Nutritional management of search and rescue dogs by Vassalotti, G et al.
RESEARCH ARTICLE
Nutritional management of search and rescue dogs
G. Vassalotti1, N. Musco1, P. Lombardi1, S. Calabrò1, R. Tudisco1, V. Mastellone1*, R. Grazioli1,
S. Bianchi2 and M. I. Cutrignelli1
1Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Napoli, Italy
2Farmina Pet-food, Department of Research and Development, Nola, Napoli, Italy
(Received 29 November 2016 – Final revision received 5 July 2017 – Accepted 10 July 2017)
Journal of Nutritional Science (2017), vol. 6, e44, page 1 of 4 doi:10.1017/jns.2017.47
Abstract
Dogs used for search and rescue (SAR) may experience continuous micro-traumas that predispose them to skeletal disorders. The aim of the present study
was to evaluate the effect of diet on osteo-articular apparatus in healthy SAR dogs. A total of sixteen SAR dogs were divided into two groups (low sup-
plementation (LS) and high supplementation (HS)) and were fed for 3 months with two experimental diets, characterised by the same protein and energy
density, but different in n-3 PUFA (6·2 v. 8·4 % of metabolisable energy), chondroitin sulfate (219·8 v. 989·0 mg/kg DM) and glucosamine (769·2 v.
1318·7 mg/kg DM) in the LS and HS groups, respectively. At recruitment all dogs showed no joint inﬂammation signs, except four that showed mild
symptoms. Haematology and serum biochemistry were performed every 30 d. Joint status was scored by physical and lameness evaluations. The sampling
effect analysis showed potential beneﬁcial effects by a decrease in a speciﬁc marker of membrane integrity (creatine kinase; CK). Comparing groups, glucose
was signiﬁcantly higher and CK was signiﬁcantly lower in the HS group; however, in both cases the levels of these parameters fell in the normal range. At
the end of the experiment, erythrocytes, Hb and packed cell volume were signiﬁcantly higher in the HS compared with the LS group. These could result in
an improvement in dogs’ performance, even if this aspect was not investigated in the present study. Concerning joint evaluation (pain on manipulation,
lameness and range of motion), no statistically signiﬁcant differences were detected between the groups and within the experimental period.
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Bone and joint diseases affect both young (birth defects) and
ageing (degenerative arthritic damage) dogs. Osteoarthritis
(OA) is a chronic and progressive articular cartilage degradation
associated with thickening, sclerosis of subchondral bone, syno-
vitis and ﬁbrosis(1). An increased incidence of OA has been
recently observed due to the increase of obesity in dogs(2,3).
OA is a disease caused by genetic and environmental factors
that increases cartilage damage promoting degenerative
changes. Since it adversely affects the quality of a dog’s life,
often leading to euthanasia, it has made dog owners much
more sensitive to orthopaedic diseases(4).
As reported by Kivranta et al.(5), vigorous running exercises alter
the loading pattern of joints. Since dogs used for search and rescue
(SAR) start their training programme at 1 year of age, their
osteo-articular apparatus is highly stressed. For this reason, SAR
dogs in the rubble showearly clinical signs of osteo-articular impair-
ment due to continuousmicro-traumas.One of the approaches for
preventing joint stress is to include in the diet speciﬁc substances
capable of both protecting and improving joint function.
Several authors reported beneﬁcial effects of some n-3 PUFA,
in particular EPA and DHA from ﬁsh oil, due to the reduction
of inﬂammatory states(6,7) by acting on pro-inﬂammatory cyto-
kine production(8) and to the improvement of synovial ﬂuid
equilibrium(9).
Several studies in dogs showed a marked reduction in arth-
ritic pain with the oral administration of glucosamine and
Abbreviations: HS, high supplementation; LS, low supplementation; ME, metabolisable energy; OA, osteoarthritis; SAR, search and rescue.
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chondroitin(10,11). Both these chondroprotectants are widely
used to treat the pain and loss of function associated with
OA. It is believed that glucosamine helps cartilage formation
and repair, and that chondroitine improves the elastic proper-
ties of cartilage and reduces painful swelling in joints(12). The
oral administration of n-3 PUFA and chondroprotectants is usu-
ally controversial. In particular, the formulation of the diet as well
as the amount of substance to use appear to be critical(13).
The aim of the present study was to evaluate the effects of a
speciﬁc supplementation (n-3 PUFA, chondroitin sulfate and
glucosamine) on the skeletal welfare in dogs used for SAR.
We hypothesised that diets supplemented with high
amounts of glucosamine, chondroitin sulfate and n-3 PUFA
would improve the osteoarthritic condition in SAR dogs.
Materials and methods
The study was reviewed by the Ethical Animal Care and Use
Committee of the University of Naples Federico II and
received formal institutional approval in accordance with
local and national law, regulations and guidelines.
A total of sixteen healthy dogs used by SAR ﬁreﬁghters (age
5·1 (SD 2·7) years; mean weight 24·7 (SD 6·9) kg; body condi-
tion score 4·5 (SD 1·0) out of 9) were selected and equally
divided into two groups (low supplementation (LS) and high
supplementation (HS)) homogeneous for age, sex and body
weight. At recruitment, no animal showed serious signs of
joint inﬂammation, only four dogs (two per group) showed
mild symptoms of inﬂammation, such as pain caused by
manipulation or decrease of range of motion and lameness.
In accordance with the habits used for Italian ﬁreﬁghter
SAR dogs, all animals were housed with their owners and fol-
lowed a home daily ﬁtness regimen (1 h) and a weekly training
(2 h) including rescuing, obedience and gym provided to ﬁt the
testing standards for rescue dogs by the International Rescue
Dog Organisation (IRO).
Before the trial the dogs were fed different diets, not specif-
ically formulated for articular management. Consequently,
before recruitment each dog was progressively adapted to
the experimental diets for 2 weeks.
Dogs were fed for 3 months with two experimental diets hav-
ing the same energy density (metabolisable energy (ME) 14·40
(SD 0·03) MJ/kg), protein concentration (22·38 (SD 0·15) %
ME) and N-free extract level (46·55 (SD 0·09) % ME), but
different content of n-3 fatty acids, mainly EPA and DHA
(6·2 v. 8·4 %ME for the LS and HS groups, respectively), chon-
droitin sulfate (219·8 v. 989·0 mg/kg DM, for the LS and HS
groups, respectively) and glucosamine (769·2 v. 1318·7 mg/kg
DM, for the LS and HS groups, respectively). Diet ingredients
and chemical composition are reported in Supplementary
Table S1.Chondroitin sulfate frompigs (concentration 90 %), glu-
cosamine from aquatic animals (concentration 95 %) and ﬁsh oil
(source of EPA and DHA) were purchased from Mazzoleni Spa.
During the ﬁrst visit the nutritional requirements according
to live weight, body condition score and training activity were
calculated for each dog. None of the dogs had received any
therapeutic treatment for at least 3 months before the onset
of the experiment.
Dogs were clinically evaluated, before and after X-rays were
taken, and the dogs underwent blood collection every 30 d for
3 months. In order to perform haematology and clinical chem-
istry analysis blood was taken in fasted dogs at 08.00 hours
from the jugular vein into plastic tubes with and without
K3-EDTA. Serum was obtained by centrifugation at 1500 g
for 15 min.
A complete blood count was performed by a Lasercyte
Haematology Analyser (Idexx Laboratories). Blood urea N,
creatinine, glucose, cholesterol, TAG, alanine amino transfer-
ase, aspartate amino transferase, γ-glutamyl transferase, alka-
line phosphatase, bilirubin, total protein, albumin, lactic
dehydrogenase and creatine kinase (CK) were measured by
an AMS Autolab spectrophotometer using reagents from
Spinreact before and after 30, 60 and 90 d of diet administra-
tion. Joint status was scored 0 (normal), 1 (mild), 2 (moderate)
and 3 (severe) as proposed by Pollmeier et al.(14) by physical
and lameness evaluations (lameness, pain on manipulation
and palpation, range of motion and joint swelling). All evalua-
tions were performed by the same veterinary practitioner, who
was blinded to the treatment groups.
The effects of sampling times and between groups were ana-
lysed by ANOVA using the Proc GLM of SAS(15) according to
the following model:
yijk = m+ Gi + Sj + G× Sij + 1ijk.
where y is the dependent variable, μ is the mean, G is the
group effect (i = LS, HS), S is the sampling effect ( j= 0, 30,
60, 90), G × S is the ﬁrst level of interaction and ε is the
error effect. When signiﬁcant differences were found in the
ANOVA, means were compared using Tukey’s test. The clin-
ical signs scores were statistically evaluated using the Wilcoxon
non-parametric test (PROC NPAR1WAY of SAS)(15).
Results
Weight loss (−3·9 and −3·7 %) and a body condition score
decrease (from 5 to 4 out of 9) were observed in both groups,
starting from day 30, though the differences were not signiﬁ-
cant (P > 0·05) (data not shown).
All biochemistry and haematology parameters fall within the
normal range for both groups. For brevity, only a few para-
meters of haematology are reported in Table 1 whereas for
serum biochemistry, bilirubin, total protein and albumin
were omitted. At the end of the experiment, erythrocytes,
Hb and packed cell volume were signiﬁcantly higher in
the HS group compared with the LS group (P< 0·01 and
P< 0·05). Glucose was signiﬁcantly (P < 0·01) higher and
CK was signiﬁcantly (P < 0·01) lower in dogs of the HS
group compared with the LS group. As shown in Table 1,
no statistical difference between groups was recorded for the
other parameters.
Regarding the sampling time, the statistical analysis con-
ducted showed a signiﬁcant reduction in creatinine, aspartate
amino transferase, γ-glutamyl transferase, cholesterol and
CK (P< 0·01), as well as blood urea N and alanine amino
transferase (P< 0·05). Considering the signiﬁcant group ×
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sampling interaction observed for glucose and CK, a particular
attention was paid to the trend during the trial of these para-
meters for each group. Regarding glucose level, the LS group
showed a slight increase from the ﬁrst to the last sampling,
which was not statistically signiﬁcant (P> 0·05); on the con-
trary in the HS group, which showed a higher baseline value
than the LS group (mean value 5·55 (SD 0·50) v. 4·22 (SD
0·78) mmol/l (100 (SD 9) v. 76 (SD 14) mg/dl), respectively),
a progressive and signiﬁcant (P< 0·05) decrease was observed.
Both groups showed a signiﬁcant (P< 0·0001) decline in CK
all through the experiment; between groups, the HS group
showed signiﬁcantly (P< 0·0006) lower CK compared with
the LS group.
In both groups, joint status (Fig. 1) was always below the
score of 1 for all parameters; no dog was found positive for
joint swelling.
No statistically signiﬁcant (P > 0·05) differences were
detected for the non-parametric data (range of motion, pain
of manipulation and lameness) considering both group
(P > 0·7) and sampling effects (P > 0·3) along the experimental
period. Indeed, a decrease of the joint score was recorded at
day 90 for pain on manipulation, lameness and range of
motion in the HS group.
X-ray images of the joints before and after the nutritional
treatment did not show any sign of osteo-articular injury.
Discussion and conclusions
All parameters fall within the normal range, thus showing,
together with the absence of clinical signs, that the nutritional
supplement had no adverse effect(16).
The diet supplementation with n-3 fatty acids, chondroitin
sulfate and glucosamine showed effects on blood count para-
meters. The difference between groups gave contrasting
results. The amount of n-3 PUFA, chondroitin sulfate and glu-
cosamine contained in the two diets did not seem to be critical
in determining their effects. Dogs from the HS group showed
higher values of erythrocytes, Hb and packed cell volume; this
may suggest an increased physical efﬁciency. Such kinds of
haematological changes may result in increasing energy pro-
duction during exercise(16) and, potentially, in improving dog
performance. Since all dogs underwent the same training pro-
gramme all through the trial, the possible beneﬁts should need
a speciﬁc evaluation of the athletic performances. CK is con-
sidered to be a marker of muscle function; therefore, falling in
the physiological range, its reduction may be suggestive of an
improvement in muscular membrane integrity. Such effect
could be due to the antioxidant properties of n-3 fatty acids
that, by contrasting the effects of reactive oxygen species,
are able to improve cell integrity(17). On the other hand,
since no difference was observed for the other markers of
muscle wellness (aspartate amino transferase and lactic
dehydrogenase), these results need to be investigated in depth.
Glucosamine and chondroitin, having been reported to
improve joint function(13), may be responsible for the
improvement in pain on manipulation, lameness and range
of motion. Indeed, such improvement could be also due to
the antioxidant effect of n-3 PUFA by improving the articularTa
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synovia(9). According to Beale(13), it is difﬁcult to identify the
exact nutraceutical treatment that leads to joint improvement.
In any event, this study shows that the combination of chon-
droitin sulfate, glucosamine and n-3 PUFA in the diet
improves joint status. The possible effects of such improve-
ment on dogs’ athletic performance as well as on their athletic
life need further study.
Supplementary material
The supplementary material for this article can be found at
https://doi.org/10.1017/jns.2017.47
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